Source:http://linkedlifedata.com/resource/pubmed/id/17596282
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
15
|
pubmed:dateCreated |
2007-7-11
|
pubmed:abstractText |
beta-catenin signaling is heavily involved in organogenesis. Here, we investigated how pancreas differentiation, growth and homeostasis are affected following inactivation of an endogenous inhibitor of beta-catenin, adenomatous polyposis coli (Apc). In adult mice, Apc-deficient pancreata were enlarged, solely as a result of hyperplasia of acinar cells, which accumulated beta-catenin, with the sparing of islets. Expression of a target of beta-catenin, the proto-oncogene c-myc (Myc), was increased in acinar cells lacking Apc, suggesting that c-myc expression is essential for hyperplasia. In support of this hypothesis, we found that conditional inactivation of c-myc in pancreata lacking Apc completely reversed the acinar hyperplasia. Apc loss in organs such as the liver, colon and kidney, as well as experimental misexpression of c-myc in pancreatic acinar cells, led to tumor formation with high penetrance. Surprisingly, pancreas tumors failed to develop following conditional pancreas Apc inactivation. In Apc-deficient acini of aged mice, our studies revealed a cessation of their exaggerated proliferation and a reduced expression of c-myc, in spite of the persistent accumulation of beta-catenin. In conclusion, our work shows that beta-catenin modulation of c-myc is an essential regulator of acinar growth control, and unveils an unprecedented example of Apc requirement in the pancreas that is both temporally restricted and cell-specific. This provides new insights into the mechanisms of tumor pathogenesis and tumor suppression in the pancreas.
|
pubmed:grant | |
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Aug
|
pubmed:issn |
0950-1991
|
pubmed:author |
pubmed-author:Ashery-PadanRuthR,
pubmed-author:BonalClaireC,
pubmed-author:CamposM LuisaML,
pubmed-author:HashimotoNaokoN,
pubmed-author:HerreraPedro LPL,
pubmed-author:KidoYoshiakiY,
pubmed-author:NodaTetsuoT,
pubmed-author:RealFrancisco XFX,
pubmed-author:StromAlessandraA,
pubmed-author:ThorelFabrizioF,
pubmed-author:TrumppAndreasA
|
pubmed:issnType |
Print
|
pubmed:volume |
134
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
2719-25
|
pubmed:dateRevised |
2007-12-3
|
pubmed:meshHeading |
pubmed-meshheading:17596282-Animals,
pubmed-meshheading:17596282-Genes, APC,
pubmed-meshheading:17596282-Genes, Tumor Suppressor,
pubmed-meshheading:17596282-Genes, myc,
pubmed-meshheading:17596282-Growth,
pubmed-meshheading:17596282-Hyperplasia,
pubmed-meshheading:17596282-Hypertrophy,
pubmed-meshheading:17596282-Mice,
pubmed-meshheading:17596282-Mice, Transgenic,
pubmed-meshheading:17596282-Organ Specificity,
pubmed-meshheading:17596282-Pancreas,
pubmed-meshheading:17596282-Pancreatic Neoplasms,
pubmed-meshheading:17596282-Signal Transduction,
pubmed-meshheading:17596282-beta Catenin
|
pubmed:year |
2007
|
pubmed:articleTitle |
Unique mechanisms of growth regulation and tumor suppression upon Apc inactivation in the pancreas.
|
pubmed:affiliation |
Department of Genetic Medicine and Development, University of Geneva Faculty of Medicine, 1 Rue Michel-Servet, CH-1211 Geneva 4, Switzerland.
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't,
Research Support, N.I.H., Extramural
|